Skip to main content
Top
Published in: Annals of Surgical Oncology 2/2011

01-02-2011 | Breast Oncology

Predictors of Breast Cancer Development in Women with Atypical Ductal Hyperplasia and Atypical Lobular Hyperplasia

Authors: Amy Whiffen, MPH, Mahmoud El-Tamer, MD, Brett Taback, MD, Sheldon Feldman, MD, Kathie-Ann Joseph, MD, MPH

Published in: Annals of Surgical Oncology | Issue 2/2011

Login to get access

Abstract

Background

Atypical ductal hyperplasia and atypical lobular neoplasia are common benign breast diseases that increase breast cancer risk. We performed a cohort analysis that compared atypia patients for additional risk factors to asses the effect on breast cancer risk by atypia status.

Methods

This longitudinal cohort study used data from the Women At Risk High-Risk Registry at Columbia University Medical Center, New York. Women with atypia were compared to women without atypia across known risk factors to determine the combined effect on breast cancer development. Odds ratios (ORs) stratified by atypia status were calculated for each risk factor of interest with 95% confidence intervals (95% CIs). P values were calculated to determine statistical significance.

Results

The study population included 1598 high-risk women, 921 (57.6%) of whom had a history of biopsy-proven atypia. The remaining 677 high-risk women (42.4%) did not have atypia. Fifty women (3.1%) developed breast cancer. Alcohol was significantly associated with the development of breast cancer (P = 0.02) and increased breast cancer risk among women with atypia (OR, 2.13; 95% CI, 0.95–4.81) compared to women without atypia (OR, 1.71). The odds of breast cancer were higher for atypia patients with first-degree relatives (OR, 1.48; 95% CI, 0.64–3.35) compared to women with a relative and no atypia diagnosis (OR, 0.98; 95% CI, 0.41–2.63). The other risk factors of interest did not differ significantly by atypia status.

Conclusions

Atypia patients who drank alcohol and had a first-degree relative with breast cancer have an increased risk of breast cancer compared to those without atypia. Continued understanding of the high-risk population will lead to more individualized protocols for risk reduction and prevention.
Literature
1.
go back to reference Schnitt SJ. Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol. 2003;27:836–41.CrossRefPubMed Schnitt SJ. Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol. 2003;27:836–41.CrossRefPubMed
2.
go back to reference Worsham MJ, Raju U, Lu M, et al. Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat. 2009;118:1–7. Worsham MJ, Raju U, Lu M, et al. Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat. 2009;118:1–7.
3.
go back to reference Degnim AC, Hartmann LC. Refining risk assessment in women with atypical hyperplasia. Curr Breast Cancer Rep. 2009;1:167–74.CrossRef Degnim AC, Hartmann LC. Refining risk assessment in women with atypical hyperplasia. Curr Breast Cancer Rep. 2009;1:167–74.CrossRef
4.
go back to reference Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312:146–51.CrossRefPubMed Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312:146–51.CrossRefPubMed
5.
go back to reference Kabat GC, Jones JG, Olson N, et al. Risk factors for breast cancer in women biopsied for benign breast disease: a nested case-control study. Cancer Epidemiol. 2010;34:34–9.CrossRefPubMed Kabat GC, Jones JG, Olson N, et al. Risk factors for breast cancer in women biopsied for benign breast disease: a nested case-control study. Cancer Epidemiol. 2010;34:34–9.CrossRefPubMed
6.
go back to reference Chun J, Pocok B, Joseph KA, et al. Breast cancer risk factors in younger and older women. Ann Surg Oncol. 2009;16:96–9.CrossRefPubMed Chun J, Pocok B, Joseph KA, et al. Breast cancer risk factors in younger and older women. Ann Surg Oncol. 2009;16:96–9.CrossRefPubMed
7.
go back to reference Sakorafas GH. The management of women at high risk for the development of breast cancer: risk estimation and prevention strategies. Cancer Treat Rev. 2003;29:79–89.CrossRefPubMed Sakorafas GH. The management of women at high risk for the development of breast cancer: risk estimation and prevention strategies. Cancer Treat Rev. 2003;29:79–89.CrossRefPubMed
8.
go back to reference Tatter PI, Gajdos C, Smith SR, et al. The prognostic significance of gail model risk factors for women with breast cancer. Am J Surg. 2002;184:11–5.CrossRef Tatter PI, Gajdos C, Smith SR, et al. The prognostic significance of gail model risk factors for women with breast cancer. Am J Surg. 2002;184:11–5.CrossRef
9.
go back to reference Prado A, Andrades P, Parada F. Recent developments in the ability to predict and modify breast cancer risk. J Plastic Reconstr Aesthet Surg. 2010;63:1581–7. Prado A, Andrades P, Parada F. Recent developments in the ability to predict and modify breast cancer risk. J Plastic Reconstr Aesthet Surg. 2010;63:1581–7.
10.
go back to reference Degnim A, Visscher DW, Berman HK, et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol. 2007;25:2671–7.CrossRefPubMed Degnim A, Visscher DW, Berman HK, et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol. 2007;25:2671–7.CrossRefPubMed
11.
go back to reference Collins LC, Baer HJ, Tamimi RM, et al. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease. Cancer. 2006;107:1240–7.CrossRefPubMed Collins LC, Baer HJ, Tamimi RM, et al. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease. Cancer. 2006;107:1240–7.CrossRefPubMed
12.
go back to reference Gill JK, Press MF, Patel AV, Bernstein L. Oral contraceptive use and risk of breast carcinoma in situ. Cancer Causes Control. 2006;17:1155–62.CrossRefPubMed Gill JK, Press MF, Patel AV, Bernstein L. Oral contraceptive use and risk of breast carcinoma in situ. Cancer Causes Control. 2006;17:1155–62.CrossRefPubMed
Metadata
Title
Predictors of Breast Cancer Development in Women with Atypical Ductal Hyperplasia and Atypical Lobular Hyperplasia
Authors
Amy Whiffen, MPH
Mahmoud El-Tamer, MD
Brett Taback, MD
Sheldon Feldman, MD
Kathie-Ann Joseph, MD, MPH
Publication date
01-02-2011
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 2/2011
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1340-5

Other articles of this Issue 2/2011

Annals of Surgical Oncology 2/2011 Go to the issue